Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY4P14 is a pseudogene of the Y RNA family, highly similar in sequence to the functional RNY4 gene, but lacking evidence of transcription to a functional RNA or protein product[3][4]. Y RNA family genes, including RNY4, are small non-coding RNAs involved in RNA stability, DNA replication, and disease processes such as cancer[1][2]. Pseudogenes like RNY4P14 may exert regulatory effects in rare cases by acting as RNA decoys or competing for binding with RNA-binding proteins[4], but there is no experimental evidence for this specific pseudogene. In contrast, the functional RNY4 gene is implicated in cancer biology and measurable in liquid biopsies as a biomarker for disease staging in anaplastic large cell lymphoma[1][2]. There is currently no validated evidence that RNY4P14 is expressed, has functional roles, or is considered a therapeutic or diagnostic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 14 (RNY4P14).